Managing mucus from COPD involves strategies that can help loosen mucus and clear it from your airway, such as staying ...

Researchers may have found a new target in chronic obstructive pulmonary disease (COPD) symptoms that could potentially save more lives. The study focused on mucus plugs, which clog airways in the ...

Please provide your email address to receive an email when new articles are posted on . More adults with COPD and mucus plugs died vs. adults with COPD and no mucus plugs. A heightened mortality risk ...

A retrospective analysis of patient data from the COPDGene study suggests that targeting mucus plugs could help prevent deaths from chronic obstructive pulmonary disease—the fourth leading cause of ...

WASHINGTON -- Mucus plugs obstructing the airways of patients with chronic obstructive pulmonary disease (COPD) were associated with higher all-cause mortality compared with no mucus plugs, according ...

Please provide your email address to receive an email when new articles are posted on . Patients with COPD and mucus plugs observed on both a baseline and 5-year follow-up CT scan vs. no mucus plugs ...

A retrospective analysis of patient data from the COPDGene study suggests that targeting mucus plugs could help prevent deaths from chronic obstructive pulmonary disease - the fourth leading cause of ...

(Boston)—Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading cause of death. Mucus plugging (mucus that accumulates in the lungs ...

Researchers at the UNC School of Medicine have developed a tool that can identify airway mucus abnormalities in patients with ...

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by cigarette smoking or long-term exposure to air pollutants. While there is ...

University Hospitals Samaritan Medical Center welcomes two providers who join an expert team to treat diseases like COPD, ...

The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a treatment option for eligible adults with uncontrolled chronic obstructive ...